Inventor
SÜLZLE DETLEV
DE19 patents
⚠️ This page may combine multiple inventors who share the name “SÜLZLE DETLEV”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
11 patentsUS9540392B2Jan 10, 2017
Thienopyrimidines
Bayer Pharma AG2 citations72
US9409889B2Aug 9, 2016
Amino-substituted imidazopyridazines
Bayer Pharma AG3 citations72
US9382255B2Jul 5, 2016
Substituted pyrrolopyrimidinylamino-benzothiazolones as MKNK kinase inhibitors
Bayer Pharma AG3 citations70
US10487092B2Nov 26, 2019
Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitors
Bayer Pharma AG1 citations60
US11311520B2Apr 26, 2022
Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitors
Bayer Pharma AG0 citations45
US10214545B2Feb 26, 2019
Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disorders
Bayer Pharma AG0 citations41
US9783543B2Oct 10, 2017
Aminoimidazopyridazines
Bayer Pharma AG0 citations41
US9745304B2Aug 29, 2017
Amidoimidazopyridazines as MKNK-1 kinase inhibitors
Bayer Pharma AG0 citations41
US9296757B2Mar 29, 2016
Substituted benzothienopyrimidines
Bayer Pharma AG0 citations41
US9675612B2Jun 13, 2017
Substituted thiazolopyrimidines
Bayer Pharma AG0 citations40
US9556181B2Jan 31, 2017
Substituted pyrazolopyrimidinylamino-indazoles
Bayer Pharma AG0 citations40
BAYER AG
6 patentsUS11773070B2Oct 3, 2023
Dihydrooxadiazinones
BAYER AG2 citations72
US11427553B2Aug 30, 2022
Dihydrooxadiazinones
BAYER AG4 citations72
US11339157B1May 24, 2022
4H-pyrrolo[3,2-c]pyridin-4-one derivatives
BAYER AG2 citations69
US12258323B2Mar 25, 2025
Dihydrooxadiazinones
BAYER AG1 citations63
US12227501B2Feb 18, 2025
3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitors
BAYER AG1 citations58
US12427153B2Sep 30, 2025
1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases
BAYER AG0 citations51